Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Programmable Anomalous Photovoltaics Enabled by Light-Electric Dual-Field Control.

Journal of the American Chemical Society·2026

Same author

Synergistic effects of ultrasound and Na<sup>+</sup> on soy protein isolate-hemp protein isolate-carboxymethyl cellulose composite emulsion gels: Evaluating the potential for low-salt gel foods.

International journal of biological macromolecules·2026

Same author

The MYC network: Hub of malignancy and blueprint for intervention.

Biochimica et biophysica acta. Reviews on cancer·2026

Same author

Feasibility and short-term comparative outcomes of a digital-assisted community-based electrical stimulation rehabilitation program for postmenopausal women with pelvic floor dysfunction: a non-randomized controlled study.

BMC women's health·2026

Same author

Fast funnel control based fixed-time consensus tracking for nonlinear multi-agent systems with unknown disturbances.

ISA transactions·2026

Same author

Depressive symptoms and perceived stress in patients with head and neck cancer undergoing intensity-modulated radiation therapy: A longitudinal study.

European journal of oncology nursing : the official journal of European Oncology Nursing Society·2026

Search research articles

Related Experiment Video

Updated: Jun 10, 2025

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

Small Molecule Compound DHPA Screened by Computer-Aided Drug Design and Molecular Dynamics Simulation Inhibits

Tianyi Liu¹, Hongli Yin², Qingyang Hu³

¹Department of Pharmacy, Dalian Women and Children's Medical Group, Dalian, Liaoning 116012, China.

|October 21, 2024

Summary

Neuroblastoma (NB), a challenging pediatric cancer, may have a new treatment. Researchers identified DHPA, a compound that effectively kills NB cells and inhibits the TrkB receptor, offering a potential therapeutic strategy.

More Related Videos

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Related Experiment Videos

Last Updated: Jun 10, 2025

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Area of Science:

Oncology
Pharmacology
Computational Biology

Background:

Neuroblastoma (NB) is a rare pediatric solid tumor with high mortality due to treatment challenges.
Tumor heterogeneity in NB complicates therapeutic strategies and necessitates novel drug discovery.

Purpose of the Study:

To identify novel therapeutic agents targeting the TrkB receptor for neuroblastoma treatment.
To screen Traditional Chinese Medicine compounds for potential TrkB inhibitory activity.

Main Methods:

Virtual screening of the YaTCM database using an E-pharmacophore approach against the TrkB receptor (PDB 4AT5).
Molecular dynamics, stretch dynamics, and US simulations to assess binding affinity and stability.
In vitro cell experiments to evaluate the efficacy of hit compounds (DHPA and 3″-demethylhexahydrocurcumin) against NB cells.

Main Results:

DHPA demonstrated significant efficacy in killing neuroblastoma cells at low concentrations.
DHPA was found to inhibit TrkB expression, downstream signaling pathways, and protein stability.
3″-demethylhexahydrocurcumin showed high IC50, indicating limited efficacy against NB cells.

Conclusions:

DHPA shows promise as a potential TrkB inhibitor for neuroblastoma therapy.
The study highlights the utility of virtual screening and molecular simulations in identifying novel anti-cancer drug candidates.
Further investigation into DHPA's mechanism of action is warranted for therapeutic development.